FFAR3在体调节的葡萄糖类1分泌中的作用
Sara Mt Persson1, Anna Casselbrant1, Aiham Alarai1,2
1Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
Biochemistry and biophysics reports
|June 24, 2024
概括
体通过自由脂肪酸受体3 (FFAR3) 抑制葡萄糖类1 (GLP-1) 的分泌,影响2型糖尿病. 向FFAR3可能会提供新的抗糖尿病治疗方法.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 胃肠病学 胃肠病学
背景情况:
- 鲁克斯-en-Y胃绕道 (RYGB) 有效治疗肥胖和2型糖尿病,部分是通过改善葡萄糖类1 (GLP-1) 水平.
- 在RYGB前,肠道生成通过通过未识别的G蛋白结合受体 (GPCRs) 抑制肠内分泌细胞来抑制GLP-1反应.
- 肠内分泌细胞上的自由脂肪酸受体 (FFAR) 是潜在的GPCRs,可以调解体效应.
研究的目的:
- 在不同的饮食和手术条件下,研究肠道肠内分泌细胞中的FFAR3表达.
- 探索体和GLP-1分泌之间的直接关系.
- 阐明参与体诱导GLP-1抑制的信号通路.
主要方法:
- 西方斑块和免疫组织化学分析了FFAR3和人体活检和小鼠模型中的肠内分泌细胞表达.
- 用GLUTag细胞研究GLP-1分泌和FFAR3信号传递.
- 评估了饮食干预和RYGB效应.
主要成果:
- 高脂肪饮食显著增加了FFAR3蛋白表达.
- 由于基质可用性减少,RYGB导致了FFAR3表达的下调.
- 体被证明可以通过FFAR3和Gα信号通路在GLUTag细胞中抑制GLP-1分泌.
结论:
- 体通过FFAR3抑制GLP-1分泌,提供了对2型糖尿病病理生理学的见解.
- FFAR3为新型抗糖尿病药物和治疗方法提供了潜在的治疗标.
相关概念视频
Glucagon-like Receptor Agonists
316
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
316
Hormones Regulating Blood Glucose
3.2K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.2K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.2K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.2K
cAMP-dependent Protein Kinase Pathways
6.3K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.3K
Insulin Secretory Vesicles
4.9K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
4.9K
Insulin: The Receptor and Signaling Pathways
1.2K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.2K


